List view / Grid view

Dr Andrew Ellis

 

article

Biosimilars: the future of competition

Earlier this year, the British Biosimilars Association (BBA), the trade…

27 April 2020 | By

Earlier this year, the British Biosimilars Association (BBA), the trade body representing the interests of biosimilar manufacturers, welcomed Dr Andrew Ellis as its new Chair. In this interview, Nikki Withers asks why biosimilars are so important for pharma and how he foresees the market evolving in the coming years.